The Transcatheter Aortic Valve Implantation Registry (TAVI-R) was established in 2018 as a clinical quality registry, supported by ACOR Ltd. In 2025, the database expanded to include all four valves of the heart; aortic, mitral, pulmonary and tricuspid. ACOR recognises the critical importance of a national cardiovascular clinical quality registry that captures data on the quality, safety, and appropriateness of transcatheter valve procedures. The registry collects a defined dataset encompassing patient characteristics, procedural techniques, device information, and patient outcomes.
The Australian Transcatheter Valve Therapies (ATVT) Database is located in Adelaide and is managed under contract with ACOR by expert staff of the South Australian Health and Medical Research Institute (SAHMRI). Following transcatheter valve procedures, data from consenting cardiac patients is entered into a sophisticated database (REDcap) by specially-trained staff on site at the participating hospitals and clinics, using leading-edge communications technology. It is SAHMRI staff who liaise directly with data managers, and SAHMRI that analyses the data for ACOR and produces feedback and reports, which can then be used by clinicians and academics for the purpose of continuous improvement of teaching and practice. Individual hospitals and clinics can use the national results to benchmark their own performance against the rest of the region.
SAHMRI and ACOR collaborate closely to manage and maintain the registry for transcatheter valve procedures across Australia. With the support of hospitals, clinicians, and device companies, the registry facilitates continuous monitoring of procedural and device safety, while also supporting research initiatives aimed at advancing patient care.
The ATVT Registry aims to:
- Improve patient care and outcomes
- Identify areas of excellence and opportunities for improvement
- Ensure sites and clinicians meet the accreditation requirements to undertake TAVI and TMVR procedures